A Review on the Drug Delivery System
DOI:
https://doi.org/10.22270/ajprd.v9i3.928Keywords:
Infected hearts, infectious disorders, liposomal diseases, respiratory diseases, micelles, transdermal diseasesAbstract
Drug administration is the mechanism or procedure by which a medicinal substance is delivered to produce a beneficial result in humans or animals. Nasal and pulmonary drug delivery pathways are gaining growing significance for the treatment of human illnesses. Such routes provide promising alternatives to the delivery of parenteral drugs particularly for peptide and protein therapies. Many drug delivery devices have been developed for this purpose, and are being tested for nasal and pulmonary delivery. These contain amongst others liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins. Nanoparticles made up of biodegradable polymers show confidence that they meet the stringent criteria imposed on such delivery systems, such as the ability to be transferred to an aerosol, stability against forces produced during aerosolisation, biocompatibility, targeting of particular sites or cell populations in the lungs, predetermined release of the drug and degradation within the lungs.
Downloads
References
2. Rao PR, Diwan PV. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Indian Pharm. 1998; 24:327–36.
3. Rao PR, Diwan PV. Permeability studies of cellulose acetate free films for transdermal use: Influence of plasticizers. Pharm Acta Helv. 1997; 72:47–51.
4. Thacharodi D, Rap KP. Development and in vitro evaluation of chitosan-based trandermal drug delivery system for the controlled delivery of propranolol hydrochloride. Biomaterials. 1995; 16:145–8.
5. Krishna R, Pandit JK. Carboxymethylcellulose-sodium based transdermal drug delivery system for propranolol. J Pharm Pharmacol. 1996; 48:367–70.
6. Bhat M, Shenoy DS, Udupa N, Srinivas CR. Optimization of delivery of betamethasone - dipropionate from skin preparation. Indian Drugs. 1995; 32:211–4.
7. Misra A, Pal R, Majumdar SS, Talwar GP, Singh O. Biphasic testosterone delivery profile observed with two different transdermal formulations. Pharm Res. 1997; 14:1264–8.
8. Thacharodi D, Rao KP. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: Development and in vitro evaluations. Biomaterials. 1996; 17:1307–11.
9. Nanda A, Khar RK. Permeability characteristics of free films were studied using the drugs such as diltiazem hydrochloride and indomethacin. Drug Dev Indian Pharm. 1994; 20:3033–44.
10. Mukhopadhyay A, Mukhopadhyay B, Basu K. Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery. FEBS Lett. 1995; 276:95–8.
11. Nanda A, Khar RK. Pulsed mode constant current iontophonetic transdermal delivery of propranalol hydrochloride in acute hypertensive and normotensive rats. Indian Drugs. 1998; 35:274–80.
12. Murthy SN, Shobha Rani HS. Comparative pharmacokinetic and pharmacodynamic evaluation of oral vs transdermal delivery of terbutaline sulphate. Indian Drugs. 1998; 35:34–6.
13. Rao MY, Vani G, Chary BR. Design and evaluation of mucoadhesive drug delivery systems. Indian Drugs. 1998; 35:558–65.
14. Murthy NS, Satheesh M. Enhancer synergism of propylene glycol and PEG -400 in terbutaline sulphate transdermal drug delivery systems. Indian Drugs. 1997; 34:224–6.
15. Tatapudy H, Madan PL. Benzoyl peroxide microcapsules I.preparation of core material. Indian Drugs. 1995; 32:239–48.
16. Kshirsagar NA, Gokhale PC, Pandya SK. Liposomes as drug delivery system in leishmaniasis. J Assoc Physicians India. 1995;43:46–8
17. Kshirasagar NA, Bodhe PV, Kotwani RN. Targeted drug delivery in visceral leishmaniasis. J Par Dis. 1997; 21:21–4.
18. Jameela SR, Kumary TV, Lal AV, Jayakrishnan A. Progressive loaded chitosan microspheres: A long acting biodegradable-controlled delivery system. J Cont Rel. 1998; 52:17–24.
19. Diwan M, Misra A, Khar RK, Talwar GP. Long-term high immune response to diphtheria toxoid in rodents with diphtheria toxoid conjugated to dextran as a single contact point delivery system. Vaccine. 1997; 15:1867–71.
20. Jain R, Shah NH, Malick AW, Rhodes CT. Controlled drug delivery by biodegradable poly (ester) devices: Different preparative approaches. Drug Dev Indian Pharm. 1998; 24:703–27.
21. Dhiman N, Khuller GK. Protective efficacy of mycobacterial 71-KDa cell wall associated protein using poly (DLlactide- co-glycolide) microparticles as carrier vehicles. FEMS Immunol Med Microbiol. 1998; 21:19–28.
22. Chandrashekar G, Udupa N. Biodegradable injectable implant systems for long term drug delivery using poly (lactic- co-glycolic) acid copolymers. J Pharm Pharmacol. 1996; 48:669–74.
23. Somayaji BV, Jariwala U, Jayachandran P, Vidyalakshmi K, Dudhani RV. Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery system. J Periodontol. 1998; 69:409–13.
24. Taware CP, Mazumdar S, Pendharkar M, Adani MH, Devarajan PV. A bioadhesive delivery system as an alternative to infiltration anesthesia. Oral Sur Oral Med Oral Pathol Oral Radiol Endodontics. 1997; 84:609–15.
25. Prasad YV, Krishnaiah YS, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Relaese. 1998; 51:281–7.
26. Krishnaiah YS, Satyanarayana S, Rama Prasad YV, Narasimha Rao S. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. J Control Release. 1998; 55:245–52.
27. Shantha KL, Ravichandran P, Rao KP. Azo polymeric hydrogels for colon targeted drug delivery. Biomaterials. 1995; 16:1313–8.
28. Khuller GK, Kapur M, Sharma S. Liposome technology for drug delivery against mycobacterial infections. Curr Pharm Des. 2004; 10:3263–74. [PubMed] [Google Scholar]49. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst. 2004; 21:387–422. [PubMed] [Google Scholar]
29. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev. 2003; 55:519–48.
30. Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology: A review. Crit Rev Ther Drug Carrier Syst. 2002; 19:99–134.
31. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001; 70:1–20.
32. Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004; 56:1257–72.
33. Florence AT. Issues in oral nanoparticle drug carrier uptake and targeting. J Drug Target. 2004;12:65–70.
34. Bummer PM. Physical chemical considerations of lipid-based oral drug delivery: Solid lipid nanoparticles. Crit Rev Ther Drug Carrier Syst. 2004; 21:1–20.
35. Florence AT, Hussain N. Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv Drug Deliv Rev. 2001; 50:S69–89.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.